Post-approval studies (Phase 4)WithdrawnNCT00312767
What this trial is testing
A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.
Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company